ENDPQ — Endo International Share News
0.000.00%
Last trade - 00:00- $0.14m
- $7.37bn
- $2.01bn
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes
Brief: Endo, Inc. Announces Proposed New Senior Secured Credit Facilities
Brief: Specialty Pharmaceutical Company Endo Launches Ibuprofen-Famotidine Tablets
Brief: Endo International Says Bankruptcy Court Entered Order Confirming, Approving Fourth Amended Version Of Plan
Drugmaker Endo receives US court approval for bankruptcy restructuring (updated)
Brief: Endo Announces Confirmation Of Plan Of Reorganization
Drugmaker Endo reaches $465 mln bankruptcy settlement with US (updated)
Drugmaker Endo reaches $465 mln bankruptcy settlement with US government
Press Digest: Wall Street Journal - Jan 11
Brief: Endo Announces Files Plan Of Reorganization To Implement Previously Announced Sale Transaction
Endo creditors seek to resolve U.S. government claims for $465 mln
Press Digest: Wall Street Journal - Nov 22
Brief: Endo International Says Risks Can Affect Ability To Enter Sale Deal And Could Impact Outcome Of Co's Voluntary Petitions For Relief Under Chapter 11 Filings
Endo sues Zydus to block generic version of Pfizer's Chantix
Brief: Endo Reports Second-Quarter 2023 Financial Results
Bankrupt Endo says US government objections imperil $600 mln in opioid settlements